Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for P31323

Entry ID Method Resolution Chain Position Source
AF-P31323-F1 Predicted AlphaFoldDB

186 variants for P31323

Variant ID(s) Position Change Description Diseaes Association Provenance
TCGA novel 56 R>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA368937554
rs1584397394
82 Q>R No ClinGen
Ensembl
rs1436699482
CA368937564
84 D>N No TOPMed
ClinGen
rs1330114726
CA368937577
85 S>C No TOPMed
ClinGen
CA164660360
rs936000837
86 E>G No TOPMed
ClinGen
CA368937585
rs1417462170
87 D>N No ClinGen
TOPMed
gnomAD
rs1031523798
CA4429823
88 G>E No ClinGen
TOPMed
gnomAD
CA368937593
rs1349918280
88 G>R No ClinGen
gnomAD
CA368937606
rs1292233393
90 E>K No gnomAD
ClinGen
rs368313660
CA4429826
92 E>A Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs775932235
CA4429827
93 A>V No ExAC
gnomAD
ClinGen
CA368937639
rs1308958978
94 A>V No ClinGen
gnomAD
CA368937642
rs1478425629
95 P>S No ClinGen
TOPMed
CA368937647
rs1290865073
96 A>S No ClinGen
gnomAD
CA368937651
rs1197111787
96 A>V No ClinGen
TOPMed
rs1286490210
CA368937660
98 A>S No ClinGen
TOPMed
rs891292930
CA164660371
98 A>V No ClinGen
TOPMed
rs1007188401
CA164660373
99 G>E No TOPMed
ClinGen
TCGA novel 100 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA368937689
rs1219279254
102 N>K No ClinGen
TOPMed
CA4429830
rs568215467
102 N>S No 1000Genomes
ExAC
TOPMed
gnomAD
ClinGen
CA4429844
rs748684280
106 I>V No ExAC
gnomAD
ClinGen
rs1477864517
COSM744232
CA368937738
108 R>* lung Variant assessed as Somatic; 0.0 impact. endometrium [Cosmic, NCI-TCGA] No gnomAD
ClinGen
cosmic curated
NCI-TCGA
rs775824400
CA4429846
108 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1034952052
CA164665976
110 T>I No Ensembl
ClinGen
rs1326909416
CA368937764
112 R>H Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
TCGA novel 117 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 121 N>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4429861
rs777219859
126 E>D No ExAC
TOPMed
gnomAD
ClinGen
rs1399701337
CA368823085
126 E>K No gnomAD
ClinGen
rs1380123627
CA368823096
126 E>V No ClinGen
TOPMed
CA368823143
rs1347522011
128 D>V No gnomAD
ClinGen
rs748864990
CA4429863
129 A>E No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 129 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs748864990
CA4429862
129 A>V No ClinGen
ExAC
TOPMed
gnomAD
CA368823215
rs1435893803
131 S>C No TOPMed
ClinGen
rs149865268
CA4429864
132 R>G No ESP
ExAC
ClinGen
rs200951450
CA4429882
134 I>M No ClinGen
1000Genomes
ExAC
gnomAD
TCGA novel 138 T>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1357784770
CA368824647
140 D>H No ClinGen
TOPMed
gnomAD
rs776909179
CA164160716
142 R>I No ClinGen
Ensembl
rs1562865559
CA368824700
143 N>S No ClinGen
Ensembl
CA368824694
rs1209902990
143 N>Y No gnomAD
ClinGen
TCGA novel 148 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4429884
rs769300018
149 C>F No ExAC
gnomAD
ClinGen
CA4429885
rs559030584
150 K>R No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA4429886
rs748545506
151 D>N No ClinGen
ExAC
gnomAD
CA368824831
rs1400376735
152 I>N No ClinGen
TOPMed
CA368824840
rs1239120460
153 L>M No ClinGen
gnomAD
CA368824847
rs1562865573
153 L>P No Ensembl
ClinGen
rs773593350
CA368824878
155 F>L No ClinGen
ExAC
gnomAD
CA164160774
rs371768848
160 P>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ESP
gnomAD
ClinGen
NCI-TCGA
rs371768848
CA164160768
160 P>R No ClinGen
ESP
gnomAD
CA164160763
rs946674589
160 P>T No ClinGen
Ensembl
TCGA novel 162 Q>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs903870287
CA164169638
163 M>T No TOPMed
ClinGen
rs1244149180
CA368828784
164 S>F Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
rs1424238319
CA368828800
165 Q>E No ClinGen
gnomAD
rs757942408
CA4429904
165 Q>H No ClinGen
ExAC
gnomAD
rs748643069
CA4429906
169 A>T No ClinGen
ExAC
gnomAD
rs1456962757
CA368828931
169 A>V No ClinGen
TOPMed
CA368828938
rs1255579209
170 M>V No ClinGen
TOPMed
rs756637383
CA4429907
174 L>F No ExAC
TOPMed
gnomAD
ClinGen
rs1396204031
CA368829036
174 L>M No ClinGen
gnomAD
CA368829111
rs1352953019
177 D>G No gnomAD
ClinGen
rs771144413
CA4429910
180 H>R No ExAC
gnomAD
ClinGen
rs3729873
CA164169725
187 D>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs3729873
CA4429913
187 D>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA368829325
rs1562869146
188 G>S No ClinGen
Ensembl
rs1184185951
CA368831775
201 I>T No TOPMed
ClinGen
rs1158900282
CA368831769
201 I>V No gnomAD
ClinGen
rs761724038
CA4429936
205 C>R No ExAC
gnomAD
ClinGen
rs761724038
CA4429937
205 C>S No ExAC
gnomAD
ClinGen
rs1392080606
CA368831884
206 D>G No gnomAD
ClinGen
rs773136065
CA4429938
206 D>N No ClinGen
ExAC
gnomAD
rs762750038
CA4429939
207 G>S No ClinGen
ExAC
TOPMed
gnomAD
CA164174417
rs1044637262
208 V>I No TOPMed
ClinGen
TCGA novel 209 G>W Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs766071087
CA4429940
210 R>G No ExAC
gnomAD
ClinGen
rs756975609
CA4429941
211 C>R No ExAC
TOPMed
gnomAD
ClinGen
TCGA novel 215 Y>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1469923855
CA368832074
216 D>H No TOPMed
ClinGen
rs764527123
CA4429943
216 D>V No ExAC
gnomAD
ClinGen
rs1213025838
CA368832118
218 R>C Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA4429944
rs754413619
218 R>H No ClinGen
ExAC
gnomAD
rs751394789
CA164174483
220 S>N No ClinGen
gnomAD
CA368832177
rs1266150485
221 F>S No ClinGen
gnomAD
CA164174503
rs202187974
228 Y>C No Ensembl
ClinGen
rs374034733
CA164174525
229 N>S No ESP
TOPMed
gnomAD
ClinGen
CA368832413
rs1442441796
230 T>I No TOPMed
ClinGen
CA368832426
rs1371140480
231 P>A No ClinGen
TOPMed
rs1178801826
CA368832492
236 I>V No ClinGen
TOPMed
gnomAD
TCGA novel 237 T>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA368832510
rs1405310138
237 T>S No ClinGen
TOPMed
CA368832528
rs1245228594
COSM3831567
239 T>A Variant assessed as Somatic; impact. breast [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
Ensembl
NCI-TCGA
CA4429950
rs747089861
241 P>L No ExAC
gnomAD
ClinGen
rs530887023
CA4429951
243 A>S No ClinGen
1000Genomes
ExAC
gnomAD
CA164142774
rs1048544863
256 I>T No ClinGen
TOPMed
CA368818520
rs1319876189
260 N>S No gnomAD
ClinGen
COSM744228
rs777810830
CA4429972
261 A>S lung [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
TCGA novel 263 K>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1271963939
CA368818579
264 R>S No ClinGen
gnomAD
CA4429974
rs770804316
266 M>I No ClinGen
ExAC
TOPMed
gnomAD
rs749115000
CA4429973
266 M>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA368818641
rs1237712646
269 S>G No gnomAD
ClinGen
rs773983070
CA164142777
269 S>N No ClinGen
ExAC
TOPMed
gnomAD
CA4429975
rs773983070
269 S>T No ExAC
TOPMed
gnomAD
ClinGen
CA164142781
rs922652968
280 L>V No gnomAD
ClinGen
rs1204029640
CA368818911
285 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No gnomAD
ClinGen
NCI-TCGA
rs746545398
CA4429998
285 R>L No ExAC
gnomAD
ClinGen
COSM1263056
rs768206192
CA368818919
287 K>E oesophagus [Cosmic] No ExAC
TOPMed
gnomAD
ClinGen
cosmic curated
CA4429999
rs768206192
287 K>Q No ClinGen
ExAC
TOPMed
gnomAD
CA4430000
rs776089075
288 V>I No ClinGen
ExAC
gnomAD
rs148976844
CA164143677
291 V>A No ESP
TOPMed
gnomAD
ClinGen
rs375279955
CA164143692
293 G>S No ESP
gnomAD
ClinGen
CA164143696
rs947463536
294 T>S No ClinGen
Ensembl
rs1562873042
CA368818968
295 K>E No Ensembl
ClinGen
rs1289685923
CA368818972
295 K>N No TOPMed
ClinGen
CA164143704
rs941339348
295 K>R No TOPMed
gnomAD
ClinGen
CA164143709
rs143772610
296 V>G No ESP
TOPMed
ClinGen
CA4430004
rs759778020
296 V>L No ExAC
gnomAD
ClinGen
rs1324127724
CA368818979
297 Y>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs756370975
CA4430007
299 D>N No ExAC
gnomAD
ClinGen
rs1049700324
CA164143720
301 E>D No Ensembl
ClinGen
COSM276898
rs201018627
CA4430030
309 S>L Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
TCGA novel 311 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1195799073
CA368819350
312 S>Y No gnomAD
ClinGen
CA368819387
rs1166000566
315 I>T No gnomAD
ClinGen
rs1461306991
CA368819382
315 I>V No ClinGen
gnomAD
rs991319621
CA164145333
317 E>V No Ensembl
ClinGen
TCGA novel 320 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA368819504
rs1562874375
324 T>A No Ensembl
ClinGen
rs1311725863
CA368819511
325 M>V No ClinGen
gnomAD
CA4430034
rs758303446
327 R>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
TCGA novel 328 K>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4430051
rs762889848
330 K>R No ClinGen
ExAC
gnomAD
CA4430053
rs751385940
333 V>A No ExAC
gnomAD
ClinGen
rs932569758
CA164145419
334 E>G No ClinGen
TOPMed
CA164145421
VAR_046549
rs3729881
CA368819659
335 E>D No ClinGen
TOPMed
UniProt
dbSNP
rs1484299990
CA368819666
336 N>S No TOPMed
gnomAD
ClinGen
CA4430054
rs754717990
337 G>D No ClinGen
ExAC
gnomAD
CA4430055
rs547463316
339 V>L No 1000Genomes
ExAC
gnomAD
ClinGen
TCGA novel 340 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 340 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1269965585
CA368819713
341 I>V No TOPMed
ClinGen
rs1269115229
CA368819723
342 A>T No gnomAD
ClinGen
rs1489977996
CA368819733
343 R>G Variant assessed as Somatic; impact. [NCI-TCGA] No TOPMed
ClinGen
NCI-TCGA
rs1031585694
CA164145430
343 R>L No Ensembl
ClinGen
CA4430059
rs777203428
345 S>L No ClinGen
ExAC
TOPMed
gnomAD
CA4430058
rs777203428
345 S>W No ClinGen
ExAC
TOPMed
gnomAD
CA368819763
rs1350023361
346 R>W No ClinGen
TOPMed
rs536349158
CA4430061
348 Q>H No 1000Genomes
ExAC
gnomAD
ClinGen
rs1159165961
CA368819801
349 Y>F No gnomAD
ClinGen
CA368819842
rs1362730841
353 L>F No ClinGen
TOPMed
gnomAD
rs747403181
CA4430062
354 A>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1048371348
CA164145444
354 A>V No ClinGen
TOPMed
rs1295807932 361 R>P No gnomAD
TCGA novel 365 A>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1379361464 367 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
gnomAD
TCGA novel 367 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1224595549 368 I>T No gnomAD
rs1184321840 368 I>V No TOPMed
gnomAD
rs1306322995 371 V>A No gnomAD
TCGA novel 374 L>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs770045302 374 L>F No ExAC
gnomAD
rs749489513
CA4430091
375 A>V No ExAC
gnomAD
ClinGen
rs1426148175
CA368820363
376 M>I No TOPMed
gnomAD
ClinGen
CA368820359
rs1562875259
376 M>T No ClinGen
Ensembl
rs771035954
CA4430092
379 Q>K No ClinGen
ExAC
gnomAD
CA164146369
rs78421605
386 G>E No Ensembl
ClinGen
rs774406745 389 M>L No ExAC
gnomAD
TCGA novel 391 I>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs79974757 392 M>I No Ensembl
TCGA novel 394 R>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1584459566 395 N>S No Ensembl
rs76105568 397 A>S No ExAC
TOPMed
gnomAD
rs76105568 397 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ExAC
TOPMed
gnomAD
NCI-TCGA
rs1319176311 405 A>T No TOPMed
TCGA novel 406 L>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs201946496 409 T>M No gnomAD
rs763679888 411 M>L No ExAC
gnomAD
rs763679888 411 M>V No ExAC
gnomAD
rs376761898 412 D>G No ESP
ExAC
TOPMed
gnomAD
rs1280371411 413 I>F No TOPMed
gnomAD
rs367760989 414 V>I No ESP
TOPMed
gnomAD
rs764908290 419 A>G No ExAC
gnomAD

No associated diseases with P31323

3 regional properties for P31323

Type Name Position InterPro Accession
domain Protein kinase domain 5 - 261 IPR000719
active_site Serine/threonine-protein kinase, active site 120 - 132 IPR008271
binding_site Protein kinase, ATP binding site 11 - 34 IPR017441

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
  • Cell membrane
  • Colocalizes with PJA2 in the cytoplasm and at the cell membrane
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

13 GO annotations of cellular component

Name Definition
cAMP-dependent protein kinase complex An enzyme complex, composed of regulatory and catalytic subunits, that catalyzes protein phosphorylation. Inactive forms of the enzyme have two regulatory chains and two catalytic chains; activation by cAMP produces two active catalytic monomers and a regulatory dimer.
centrosome A structure comprised of a core structure (in most organisms, a pair of centrioles) and peripheral material from which a microtubule-based structure, such as a spindle apparatus, is organized. Centrosomes occur close to the nucleus during interphase in many eukaryotic cells, though in animal cells it changes continually during the cell-division cycle.
ciliary base Area of the cilium (also called flagellum) where the basal body and the axoneme are anchored to the plasma membrane. The ciliary base encompasses the distal part of the basal body, transition fibers and transition zone and is structurally and functionally very distinct from the rest of the cilium. In this area proteins are sorted and filtered before entering the cilium, and many ciliary proteins localize specifically to this area.
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
dendritic shaft Cylindric portion of the dendrite, directly stemming from the perikaryon, and carrying the dendritic spines.
dendritic spine A small, membranous protrusion from a dendrite that forms a postsynaptic compartment, typically receiving input from a single presynapse. They function as partially isolated biochemical and an electrical compartments. Spine morphology is variable:they can be thin, stubby, mushroom, or branched, with a continuum of intermediate morphologies. They typically terminate in a bulb shape, linked to the dendritic shaft by a restriction. Spine remodeling is though to be involved in synaptic plasticity.
extracellular exosome A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
glutamatergic synapse A synapse that uses glutamate as a neurotransmitter.
membrane raft Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
neuronal cell body The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites.
perinuclear region of cytoplasm Cytoplasm situated near, or occurring around, the nucleus.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

6 GO annotations of molecular function

Name Definition
cAMP binding Binding to cAMP, the nucleotide cyclic AMP (adenosine 3',5'-cyclophosphate).
cAMP-dependent protein kinase inhibitor activity Binds to and stops, prevents or reduces the activity of a cAMP-dependent protein kinase.
cAMP-dependent protein kinase regulator activity Modulation of the activity of the enzyme cAMP-dependent protein kinase.
protein domain specific binding Binding to a specific domain of a protein.
protein kinase A catalytic subunit binding Binding to one or both of the catalytic subunits of protein kinase A.
ubiquitin protein ligase binding Binding to a ubiquitin protein ligase enzyme, any of the E3 proteins.

7 GO annotations of biological process

Name Definition
fatty acid metabolic process The chemical reactions and pathways involving fatty acids, aliphatic monocarboxylic acids liberated from naturally occurring fats and oils by hydrolysis.
intracellular signal transduction The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell.
learning Any process in an organism in which a relatively long-lasting adaptive behavioral change occurs as the result of experience.
modulation of chemical synaptic transmission Any process that modulates the frequency or amplitude of synaptic transmission, the process of communication from a neuron to a target (neuron, muscle, or secretory cell) across a synapse. Amplitude, in this case, refers to the change in postsynaptic membrane potential due to a single instance of synaptic transmission.
negative regulation of cAMP-dependent protein kinase activity Any process that stops, prevents or reduces the frequency, rate or extent of cAMP-dependent protein kinase activity.
response to antipsychotic drug Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antipsychotic drug stimulus. Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect.
response to clozapine Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a clozapine stimulus.

23 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P07278 BCY1 cAMP-dependent protein kinase regulatory subunit Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) SS
P00514 PRKAR1A cAMP-dependent protein kinase type I-alpha regulatory subunit Bos taurus (Bovine) EV
P00515 PRKAR2A cAMP-dependent protein kinase type II-alpha regulatory subunit Bos taurus (Bovine) EV
P31322 PRKAR2B cAMP-dependent protein kinase type II-beta regulatory subunit Bos taurus (Bovine) EV
Q5ZM91 PRKAR1A cAMP-dependent protein kinase type I-alpha regulatory subunit Gallus gallus (Chicken) SS
P16905 Pka-R1 cAMP-dependent protein kinase type I regulatory subunit Drosophila melanogaster (Fruit fly) PR
P81900 Pka-R2 cAMP-dependent protein kinase type II regulatory subunit Drosophila melanogaster (Fruit fly) PR
Q96M20 CNBD2 Cyclic nucleotide-binding domain-containing protein 2 Homo sapiens (Human) PR
P10644 PRKAR1A cAMP-dependent protein kinase type I-alpha regulatory subunit Homo sapiens (Human) EV
P31321 PRKAR1B cAMP-dependent protein kinase type I-beta regulatory subunit Homo sapiens (Human) EV
P13861 PRKAR2A cAMP-dependent protein kinase type II-alpha regulatory subunit Homo sapiens (Human) PR
P12367 Prkar2a cAMP-dependent protein kinase type II-alpha regulatory subunit Mus musculus (Mouse) PR
Q9D5U8 Cnbd2 Cyclic nucleotide-binding domain-containing protein 2 Mus musculus (Mouse) PR
P12849 Prkar1b cAMP-dependent protein kinase type I-beta regulatory subunit Mus musculus (Mouse) PR
Q9DBC7 Prkar1a cAMP-dependent protein kinase type I-alpha regulatory subunit [Cleaved into: cAMP-dependent protein kinase type I-alpha regulatory subunit, N-terminally processed] Mus musculus (Mouse) SS
P31324 Prkar2b cAMP-dependent protein kinase type II-beta regulatory subunit Mus musculus (Mouse) PR
P05207 PRKAR2A cAMP-dependent protein kinase type II-alpha regulatory subunit Sus scrofa (Pig) SS
P07802 PRKAR1A cAMP-dependent protein kinase type I-alpha regulatory subunit Sus scrofa (Pig) SS
P81377 Prkar1b cAMP-dependent protein kinase type I-beta regulatory subunit Rattus norvegicus (Rat) PR
P09456 Prkar1a cAMP-dependent protein kinase type I-alpha regulatory subunit Rattus norvegicus (Rat) SS
P12368 Prkar2a cAMP-dependent protein kinase type II-alpha regulatory subunit Rattus norvegicus (Rat) PR
P12369 Prkar2b cAMP-dependent protein kinase type II-beta regulatory subunit Rattus norvegicus (Rat) PR
P30625 kin-2 cAMP-dependent protein kinase regulatory subunit Caenorhabditis elegans SS
10 20 30 40 50 60
MSIEIPAGLT ELLQGFTVEV LRHQPADLLE FALQHFTRLQ QENERKGTAR FGHEGRTWGD
70 80 90 100 110 120
LGAAAGGGTP SKGVNFAEEP MQSDSEDGEE EEAAPADAGA FNAPVINRFT RRASVCAEAY
130 140 150 160 170 180
NPDEEEDDAE SRIIHPKTDD QRNRLQEACK DILLFKNLDP EQMSQVLDAM FEKLVKDGEH
190 200 210 220 230 240
VIDQGDDGDN FYVIDRGTFD IYVKCDGVGR CVGNYDNRGS FGELALMYNT PRAATITATS
250 260 270 280 290 300
PGALWGLDRV TFRRIIVKNN AKKRKMYESF IESLPFLKSL EFSERLKVVD VIGTKVYNDG
310 320 330 340 350 360
EQIIAQGDSA DSFFIVESGE VKITMKRKGK SEVEENGAVE IARCSRGQYF GELALVTNKP
370 380 390 400 410
RAASAHAIGT VKCLAMDVQA FERLLGPCME IMKRNIATYE EQLVALFGTN MDIVEPTA